本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Mesoblast Limited

13.34
-0.1100-0.82%
成交量:7.14万
成交额:95.35万
市值:16.93亿
市盈率:-14.97
高:13.56
开:13.28
低:13.14
收:13.45
数据加载中...

公司资料

公司名字:
Mesoblast Limited
交易所:
NASDAQ
成立时间:
2004
员工人数:
73
公司地址:
55 Collins Street,Level 38,Melbourne,Victoria,Australia
邮编:
3000
传真:
61 3 9639 6030
简介:
Mesoblast Limited于2004年6月8日在澳大利亚成立。该公司在开发同种异体细胞药物方面处于世界领先地位。该公司利用其专有的间充质谱系细胞治疗技术平台建立了广泛的商业产品和后期产品候选产品组合。

董事

名称
职位
Jane Bell
Chairman of the board
Silviu Itescu
Chief Executive Officer and Director
Eric Rose
Chief Medical Officer and Director
Philip Facchina
Director
Philip Krause
Director
William Burns
Director

股东

名称
职位
Silviu Itescu
Chief Executive Officer and Director
Andrew Chaponnel
Interim Chief Financial Officer
Eric Rose
Chief Medical Officer and Director
Fiona See
SVP and Head, Translational Research
Geraldine Storton
Head of Regulatory Affairs and Quality Management
Justin Horst
Head of Manufacturing
Michael Schuster
Pharma Partnering
Niva Sivakumar
Joint Company Secretary
Paul Hughes
Joint Company Secretary
Peter Howard
Group General Counsel and Corporate Executive